AT-007

• Description:

  AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  425.4

• Molecular Formula:

  C17H10F3N3O3S2

• Notes:

  Research use only, not for human use.

• Receptor:

  Aldose Reductase

• CAS Number:

  2170729-29-8